Perception Training for Asthma
(ASP RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help older adults with asthma become more aware of their breathing limitations, potentially leading to improved asthma management. Participants will learn to recognize airway obstruction through feedback on their breathing and receive motivational support to change their asthma care habits. The study involves 300 adults over 60 with uncontrolled asthma who use daily or as-needed controller medications. Sessions, including the PEF Interventional Session (focused on peak expiratory flow measurement), will aim to improve lung function, asthma control, and quality of life, while reducing emergency visits. Ideal candidates have asthma that disrupts their daily activities and have had the condition for over a year. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance asthma management for older adults.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants are on controller medications, which suggests you may continue your current asthma treatments.
What prior data suggests that this perception training intervention is safe for older adults with asthma?
Research has shown that the PEF Interventional Session, which combines feedback on peak expiratory flow (PEF) with motivational interviewing, is safe. In an earlier study, patients who participated in this program did not report any serious side effects. This approach helps participants understand and manage their asthma by learning to recognize airflow limitations.
The initial trial found that this method not only improved asthma symptoms but was also well-tolerated by older adults, who did not experience harmful side effects. The intervention focuses on education and self-awareness, which typically carries fewer risks than treatments involving medication.
Overall, current evidence supports the safety of this intervention for older adults managing asthma.12345Why are researchers excited about this trial?
Researchers are excited about perception training for asthma because it focuses on retraining how people perceive their breathing, which is a fresh approach compared to traditional medications like inhalers or bronchodilators. Unlike typical treatments that aim to directly open airways or reduce inflammation, this method works on improving the patients' awareness and response to their breathing patterns. This could lead to better self-management of asthma symptoms and possibly reduce the reliance on medications, offering a complementary strategy to existing treatments.
What evidence suggests that this trial's treatments could be effective for asthma?
Research has shown that teaching older adults to recognize their asthma symptoms more accurately can lead to better health outcomes. In this trial, participants in the PEF group with active booster will receive feedback on their ability to blow air out of their lungs, combined with motivational conversations. This aims to improve their ability to exhale quickly and increase awareness of breathing difficulties. Previous studies have tested this approach and shown promising results in improving overall asthma control. These findings suggest that when older adults better understand their breathing issues, they can manage their asthma more effectively.26789
Who Is on the Research Team?
Juan Wisnivesky, MD, DrPH
Principal Investigator
Division Chief, General Internal Medicine
Are You a Good Fit for This Trial?
This trial is for individuals aged 60 or older with uncontrolled asthma despite being on controller medications. Participants will be recruited from underserved inner-city medical practices in New York City. They must not have other health conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 intervention or control sessions over 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Booster Session
Participants receive an active or control booster session at the 6-month time point
What Are the Treatments Tested in This Trial?
Interventions
- Active booster
- Control Booster
- Control Sessions
- PEF Interventional Session
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
Yeshiva University
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Albert Einstein College of Medicine
Collaborator